MedPath

Methadone Maintenance and HIV Prevention: A Window of Opportunity in China

Not Applicable
Completed
Conditions
Capacity Building
Drug Use
HIV/AIDS
Interventions
Behavioral: MMT CARE
Registration Number
NCT01532609
Lead Sponsor
University of California, Los Angeles
Brief Summary

This study is an intervention pilot that integrates the current methadone maintenance treatment (MMT) program in China with psychosocial and behavioral components in order to address the critical link between drug use and HIV/AIDS.

The intervention pilot proceeds in two phases in Sichuan, China. In Phase 1, we developed the intervention manuals and supporting materials, and finalized assessment measures and implementation procedures. In Phase 2, we conducted an intervention pilot across 6 MMT clinics involving 41 service providers and 179 clients, and followed up at three, six, and nine months.

Detailed Description

The implementation of the MMT program in China is one of the most significant measures ever taken by the Chinese government to address drug use and HIV prevention challenges. In 2004, China launched a series of MMT programs at eight pilot clinics in five provinces. By December 2007, 503 MMT clinics had been established nationwide across 23 provinces. Several studies have found that positive outcomes in drug use, criminality, and employment were associated with participation in MMT. However, special challenges are facing the current MMT programs are facing: 1) clients' drop-out rates are high; and 2) providers at MMT clinics do not have sufficient training, and some of them hesitate to serve the population. We have recognized the urgent need and conducted the study to address these challenges.

The intervention pilot proceeds in two phases in Sichuan, China. In Phase 1, we developed the intervention manuals and supporting materials, and finalized assessment measures and implementation procedures. In Phase 2, we conducted an intervention pilot across 6 MMT clinics involving 41 service providers and 179 clients, and followed up at three, six, and nine months.

The specific aims of the proposed study are:

Specific Aim 1: To assess the feasibility and acceptability of the MMT PLUS intervention with process evaluation and participant feedback.

Specific Aim 2: To examine primary outcomes on whether service providers in the intervention group, compared to providers in the standard care, will demonstrate improved adherence to MMT protocol, decrease in prejudicial attitudes, increase in comfort working with MMT clients, increase in motivating clients and making personalized risk management plan.

Specific Aim 3: To explore secondary outcomes on whether MMT clients in the intervention group, compared to clients in the standard care, will report increased motivation to change, improved psychological and physical health, increased positive support network, and reduced HIV risk behavior.

Specific Aim 4: To investigate exploratory outcomes on whether MMT clients in the intervention group, compared to clients in the standard care, will report improved MMT treatment retention and decreased drug use.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
220
Inclusion Criteria

Service providers

  • Age 18 and above
  • Currently working in MMT clinic
  • Informed consent

MMT clients

  • Age 18 or over
  • Currently enrolled in MMT
  • Informed consent
Read More
Exclusion Criteria

Service providers

  • Anyone who does not meet the inclusion criteria.

MMT clients:

  • Psychosis, neurological damage, as judged by an interviewer in consultation with a clinical supervisor inability to give informed consent
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
InterventionMMT CAREIntervention group service providers received four training sessions (plus reunion sessions) on MMT protocol, reducing stigma and its impact, maintaining positive interactions with clients, and motivational interviewing skills. The participating providers are required to conduct three individual motivational sessions with their clients upon completion of the intervention sessions.
Primary Outcome Measures
NameTimeMethod
Service provider's job satisfactionChanges from baseline to 3-, 6- and 9-month follow-up
Service provider's prejudical attitude towards drug usersChanges from baseline to 3-, 6- and 9-month follow-up
Provide-client interactionChanges from baseline to 3-, 6- and 9-month follow-up
Provider's perceived stigma due to work with drug using populationChanges from baseline to 3-, 6- and 9-month follow-up
Service provider's perceived risk at workChanges from baseline to 3-, 6- and 9-month follow-up
Service provider's perceived institutional supportChanges from baseline to 3-, 6- and 9-month follow-up
Service providers' MMT knowledgeChanges from baseline to 3-, 6- and 9-month follow-up
Secondary Outcome Measures
NameTimeMethod
Client's perceived stigma from MMT clientsChanges from baseline to 3-, 6- and 9-month follow-up
Client's drug avoidance self-efficacyChanges from baseline to 3-, 6- and 9-month follow-up
Client's physical healthChanges from baseline to 3-, 6- and 9-month follow-up
Client's social supportChanges from baseline to 3-, 6- and 9-month follow-up
Client's readiness to changeChanges from baseline to 3-, 6- and 9-month follow-up
Client's drug using behaviorChanges from baseline to 3-, 6- and 9-month follow-up
MMT client's mental healthChanges from baseline to 3-, 6- and 9-month follow-up

Trial Locations

Locations (1)

Sichuan Provincial Center for Disease Control and Prevention

🇨🇳

Chengdu, Sichuan, China

© Copyright 2025. All Rights Reserved by MedPath